A Clinical Study Evaluaing the Efficacy, Safety, and Patient Satisfaction of Injectable Hylaronic Acid With 0.3% Lidocain Hydrochloride, Prevelle Silk, for Superficial, Vertical Perioral Lines and Superficial, Horizontal, Lateral Canthal Lines

Inclusion Criteria: * Females and males in good general health between 35 to 65 years of age. * Must be willing to give and sign a HIPPA form, informed consent form and a photographic release form * Patient is planning to undergo Prevelle Silk treatment * A potential subject's must exhibit: A. moderate to severe superficial, vertical perioral and horizontal canthus lines * For FEMALE PATIENT OF CHILDBEARING POTENTIAL, must have had a regular menstrual cycle prior to study entry (a female is considered of childbearing potential unless she is postmenopausal, without a uterus and/or both ovaries, or has had a bilateral tubal ligation) and is willing to use an acceptable form of birth control during the entire course of the study \[i.e., acceptable methods of birth control are oral contraceptives, contraceptive patches/rings/implants Norplanit®, Depo-Provena®, double-barrier methods (e.g. condoms and spermicide), abstinence and vasectomies of partner with a documented second acceptable method of birth control should the patient become sexually active\]. All systemic birth control measures must be in consistent use at least 30 days prior to study participation * Negative urine pregnancy test results at the time of study entry (if applicable) * Must be willing to comply with study regimen and complete the entire course of the study. Exclusion Criteria: * A patient with any UNCONTROLLED systemic disease. A potential patient in whom therapy for a systemic disease is not yet stab…